Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:360-363

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, B.
Right arrow Articles by Ogihara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, B.
Right arrow Articles by Ogihara, T.
Right arrowPubmed/NCBI databases
*Substance via MeSH

(Hypertension. 1996;27:360-363.)
© 1996 American Heart Association, Inc.


Articles

Parathyroid Hormone–Related Protein Inhibits Endothelin-1 Production

Bingbing Jiang; Shigeto Morimoto; Keisuke Fukuo; Atsushi Hirotani; Michio Tamatani; Takeshi Nakahashi; Akira Nishibe; Tadaaki Niinobu; Shigeki Hata; Shaoyan Chen; Toshio Ogihara

From the Department of Geriatric Medicine, Osaka (Japan) University Medical School.

Abstract The effect of human parathyroid hormone–related protein, a powerful vasodilator, on endothelin-1 production in cultured bovine pulmonary arterial endothelial cells was studied. Treatment with parathyroid hormone–related protein(1-34) at concentrations of 10-9 to 10-6 mol/L for 24 hours caused dose-dependent suppression of the secretion of endothelin-1, with maximal suppression at 10-7 mol/L to 74% of the control value. This inhibitory effect was completely abolished by coincubation with 100 ng/mL pertussis toxin, an inhibitor of GTP binding protein. Furthermore, addition of NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthase, at 10-3 mol/L significantly blocked the suppressive effect of parathyroid hormone–related protein(1-34) on endothelin-1 secretion, and further addition of 5x10-3 mol/L L-arginine significantly attenuated the blocking effect of NG-monomethyl-L-arginine. Parathyroid hormone–related protein(1-34) at 10-7 mol/L resulted in an approximately fivefold increase in intracellular cGMP level. Northern blot analysis revealed that parathyroid hormone–related protein(1-34) inhibited both basal and thrombin-induced endothelin-1 gene expression. These findings suggest that the vasodilating property of parathyroid hormone–related protein may be mediated in part through its inhibitory effect on endothelin-1 production, which is probably mediated through nitric oxide and cGMP in endothelial cells. Thus, a feedback regulatory mechanism may exist between parathyroid hormone–related protein and endothelin-1 in the vascular wall.


Key Words: parathyroid hormone • endothelins • nitric oxide • pertussis toxins




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi
Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues
Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438.
[Abstract] [Full Text] [PDF]